Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, ...
Kailera is building out a weight-loss drug pipeline with both injectables and pills, with four candidates in various trial ...
This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results